Company Green and Hill Industries, Inc Other OTC
Equities
GHIL
US39260U1060
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2014 | Weight | Delta |
---|---|---|---|
Oil and Gas Sector
100.0
%
| 0 | 100.0 % | - |
Sales per region
USD in Million | 2014 | Weight | Delta |
---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ross Rebagliati
CEO | Chief Executive Officer | - | 14-03-16 |
Patrick Smyth
PSD | President | - | 14-03-16 |
Lorne Green
SEC | Corporate Secretary | - | 13-01-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Smyth
PSD | President | - | 14-03-16 |
Lorne Green
SEC | Corporate Secretary | - | 13-01-11 |
Ross Rebagliati
CEO | Chief Executive Officer | - | 14-03-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 101,139,797 | 101,139,797 ( 100.00 %) | 0 | 100.00 % |
Stock B | 0 | 2,000 | 0 | 0 |
Company contact information
Green & Hill Industries, Inc.
102A-1075 Bay Street Suite 254
M5S 2B2, Toronto
+
Sector
1st Jan change | Capi. | |
---|---|---|
+35.04% | 5.92B | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
-7.89% | 1.68B | |
+0.09% | 1.65B | |
-12.97% | 1.53B |